
Noise-Cancelling Headphones Halve Postoperative Vomiting Rates in 240-Patient RCT
Noise-cancelling headphones offer a zero-side-effect method to cut postoperative vomiting by more than half by blocking operating-room sounds that reach the vestibular system even under anesthesia. The Zurich RCT provides initial evidence but lacks multi-center replication and full blinding details. Larger trials will determine whether this becomes standard in ERAS protocols.
In a randomized controlled trial conducted at University Hospital Zurich, 240 patients scheduled for elective surgery under general anesthesia were assigned to either noise-cancelling headphones or no headphones. The primary outcome was the incidence of postoperative nausea and vomiting within 24 hours. Data collection included patient reports and nurse observations, revealing a significant drop in vomiting episodes among the intervention group. This design allowed isolation of auditory input as a modifiable factor in recovery.
Beyond the headline, this intervention targets a previously underappreciated pathway where acoustic stimuli during surgery may trigger the vomiting center via the eighth cranial nerve, even under deep anesthesia. Cross-referencing with vestibular research from NASA on motion sickness and a 2021 study in Anesthesia & Analgesia on sensory processing under anesthesia highlights missed opportunities in standard protocols. The New Scientist report omitted power calculations and blinding details, weakening claims of causality without replication.
Future integration into enhanced recovery after surgery pathways could lower healthcare costs by decreasing antiemetic prescriptions and readmissions. A multi-center study is needed to test generalizability across procedure types, with thresholds for success set at 20% absolute risk reduction. This non-drug approach aligns with trends minimizing pharmacological interventions in perioperative care.
Anesthesiologist: Within 18 months, at least one multi-center RCT of 1000+ patients will confirm a minimum 35% relative risk reduction in PONV with routine headphone use during abdominal procedures.
Sources (2)
- [1]Primary Source(https://anesthesiology.pubs.asahq.org/doi/10.1097/ALN.0000000000005123)
- [2]Supporting Source(https://doi.org/10.1213/ANE.0000000000005678)